An effort of 95 million dollars for the study of drugs are already recommended for children

Children taking prescription drugs, too.

"But only a minority of these drugs has actually been studied in children to set which are safe and effective and to find out the correct dosage.""Virtually all paediatric use is off-label", and doctors make their best estimate of the appropriate dose, Danny Benjamin, a Professor of Pediatrics at the Duke University School of medicine, said the health Blog.

The assumption is incorrect for a third of drugs, said. Body weight is used to make rough estimates, but that does not have the differently that medications are metabolized by infants and children.

Some brand name drugs get escudri?ados under a program that gives drug manufacturers to 6 additional months of patent protection to carry out studies requested by the FDA in children. And experimental drugs to the FDA approval must evaluate the impact on children if likely utilizarlos.Pero which leaves a gap of knowledge for the host of generic medications used for everything from infectious diseases treat cancer.

A new NIH-supported for both as 95 million dollars are trying to put a dent in the issue.a initiative over the next seven years, Pediatric trials network carried out 16 trials (mostly register 100-200 participants) to discuss drugs for a variety of conditions.

Benjamin will lead the PTN, involving researchers from several hospitales.Medicamentos antihypertensive are likely to be one of the first study, said.Dosing information for children who need these drugs, including obese children, those who have had transplants of organs and the newly born is greatly needed, says.

Trials of antibiotics are also crucial, says Benjamin.Las statistics that was launched at the beginning of this year showed a strong increase in the number of children hospitalised with MRSA, and dangerous staph ECA is "a new concern in the health of children".Sin embargo on all not established dose for many drugs, said.

Information generated by the tests will be made available to the public, says Benjamin.Y is expected that the FDA will use any useful information to change the label of proper meds, says.

Further reading:

Image: iStockphoto

View the original article here